Monroe Capital Provides $75 Million Senior Secured Credit Facility to Alora Pharmaceuticals, LLC
Chicago, IL, September 17, 2013
Monroe Capital LLC today announced the funding of a $75 million senior secured credit facility to support the growth of Alora Pharmaceuticals, LLC (“Alora”), the parent company of Avion Pharmaceuticals, LLC and Acella Pharmaceuticals, LLC.
Based in Alpharetta, Georgia, Alora develops and manufactures pharmaceuticals, including prenatal vitamins, nutraceuticals, dermatologics and innovative products for gastroenterology and endocrinology disorders. Alora maintains a broad portfolio of both branded and non-branded products, focusing on identifying opportunities to acquire and enhance the market potential of commercially available dietary supplement products and late-stage development drugs to fulfill unmet medical and dietary needs. Alora’s flagship product, Prenate® is a leading brand name in the prescription prenatal vitamin market.
About Monroe Capital
Monroe Capital LLC is a leading provider of senior and junior debt and equity co-investments to middle-market companies in the U.S. and Canada. Investment types include unitranche financings, cash flow and enterprise value based loans, acquisition facilities, mezzanine debt, second lien or last-out loans and equity co-investments. Monroe Capital prides itself on its flexible investment approach and its ability to close and fund transactions quickly. Monroe is committed to being a value-added and user-friendly partner to owners, senior management and private equity sponsors. To learn more about Monroe Capital LLC, visit www.monroecap.com.